Compass… updates on [synthetic polymorph] psilocybin…
Compass sinks after depression therapy results… the net loss for the year [2021] was $71.7 million… …Compass doesn’t have any meaningful revenue… continues to explore… indications and therapeutic approaches… there were 12 people in the [synthetic psilocybin polymorph] study… who exhibited suicidal behavior or thoughts, or who showed intent to harm themselves. Original Article (Green Market…
Recent Comments